ClinicalTrials.gg
Active, not recruitingNCT06647849MISC-TRAINUpdated Jun 25, 2026

Interest of Simulation Training on the Announcement of Early Pregnancy Loss on the Psychological Impact of the Patients

An interventional study of centers whose interns receive simulation training in the announcement of early spontaneous miscarriage between the 2 inclusion phases and centers with standard in-house management of spontaneous miscarriage/pregnancy arrested in the emergency department in Early Pregnancy Loss and Spontaneous Miscarriage, sponsored by University Hospital, Angers. Active, not recruiting at 28 sites in France. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-25.

Sponsored by University Hospital, Angers · Not applicable, Interventional, and Prevention

How we know · 2 judgments

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
607
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 27 studies in Abortion, Spontaneous with a site in France — 7 open to participants now, 8 under way, none of them phase 3. Abortion, Spontaneous · France.

Enrollment
3rd of 14
607 · median 210
Started
2024
with 1 other
No phase
12 of 27
5 open now
Registered
24th of 27
by date

Among the 27 studies in Abortion, Spontaneous with a site in France, this one is the 3rd largest by enrollment of the 14 interventional ones that give a count, is one of 2 that started in 2024, is one of 12 with no phase, and was the 24th registered.

Abortion, Spontaneous

221 studies on the registry are indexed under Abortion, Spontaneous; 44 are open to participants now.

Browse Abortion, Spontaneous studies →

Open to participants now

7 of the 27 studies in Abortion, Spontaneous with a site in France are open now. Recruiting first, the newest first:

2 more — sign in →

All 7 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 36 Abortion, Spontaneous studies recruiting now, 11 (31%) set no upper age limit and 25 (69%) stop at 75 or younger; 8 take children under 18; 9 take healthy volunteers.

This study: 18 Years and older · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 27 studies in Abortion, Spontaneous with a site in France, or all of them as a file.
02

Study summary

Early pregnancy loss (or spontaneous miscarriage) is the loss of a pregnancy before 14 weeks of amenorrhea. Its incidence is estimated at between 10 and 15%, and increases with maternal age.

Early pregnancy loss can have major psychological consequences for the woman, her partner and the couple in the aftermath, as well as on the experience and progress of a future pregnancy.

In France, the vast majority of miscarriages are diagnosed in gynecological emergencies by interns still in training. Interns, sometimes at the beginning of their training, may find it difficult to announce a miscarriage, and may do so in a way that is clumsy or not adapted to the woman's emotions, which can lead to a bad experience for her. This bad experience could lead to psychological distress, post-traumatic stress and/or impair future fertility.

The initiators of this project have already carried out a before-and-after, single-center study, showing a significant improvement in the specific Perinatal Grief Scale score following specific training for interns in first-trimester pregnancy loss.

To date, no multicenter randomized study has been conducted to assess the impact of first-trimester pregnancy loss on women's psychological experience.

03

Conditions studied

  • Early Pregnancy Loss
  • Spontaneous Miscarriage

Browse trials for

Keywords

  • spontaneous miscarriage
  • early pregnancy loss
  • training for interns
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult patient
  • Patient presenting to gynaecological emergency department
  • Patient with a diagnosis of terminated pregnancy or spontaneous expulsion of a pregnancy \< 14 weeks' amenorrhea
  • Patient whose spontaneous miscarriage was announced by an intern
  • Patient affiliated to or benefiting from a social security scheme
  • Patient having signed an form

Exclusion criteria

Exclusion Criteria:

  • Unwanted pregnancy
  • Spontaneous hemorrhagic miscarriage requiring surgical management
  • Ectopic pregnancy
  • Miscarriage resulting from assisted reproduction treatment
  • Patient with history of miscarriage ≥ 3
  • Poor understanding of the French language
  • Person deprived of liberty by judicial or administrative decision
  • Person under forced psychiatric care
  • Person subject to a legal protection measure
  • Person unable to give consent
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
607 participants (actual)

Study arms

  • Experimental
    Arm "with training"

    Arm "with training": centers whose interns receive simulation training in the announcement of early spontaneous miscarriage between the 2 inclusion phases.

    Procedure: centers whose interns receive simulation training in the announcement of early spontaneous miscarriage between the 2 inclusion phases

  • Other
    "Untrained" arm

    "Untrained" arm: centers with standard in-house management of spontaneous miscarriage/pregnancy arrested in the emergency department.

    Other: centers with standard in-house management of spontaneous miscarriage/pregnancy arrested in the emergency department

Interventions

  • Procedurecenters whose interns receive simulation training in the announcement of early spontaneous miscarriage between the 2 inclusion phases

    The simulation training sessions for the announcement consultation are set up directly in the centers participating in the "with training" arm of the study, after the first phase of patient inclusion. These sessions will take place "in situ" in the center's maternity ward, and will be run by a single team trained in simulation and announcement. This team of trainers is identical for all centers randomized in the "with training" arm, and is made up of two trainers: an obstetrician-gynecologist and a psychologist.

  • Othercenters with standard in-house management of spontaneous miscarriage/pregnancy arrested in the emergency department

    In the participating centers included in the "no training" arm, interns will have no specific training in announcement. Patients will receive information concerning the diagnosis of a terminated pregnancy or miscarriage from interns not trained in simulation. During the course of the study, training in the announcement of a miscarriage will be offered to interns from centers in the "no training" group.

06

What researchers measure

Primary outcomes

  1. evaluate the impact of specific training for interns in simulated early miscarriage announcements on patients' psychological experiences

    Time frame: The primary endpoint was the significant change in the Perinatal Grief Scale at 3 months post-miscarriage linked to the implementation of the simulation training

Secondary outcomes

  1. Evaluation of the impact on the psychological experience of short-term miscarriage at 1 month

    Time frame: Modification of the "Impact of event scale-revised" post-traumatic stress score at 1 month

  2. evaluation of the patient's feelings about the miscarriage announcement made by the intern at 1 month

    Time frame: Modification of the patient's perception of the announcement of the miscarriage by the resident, using a 1-month questionnaire

  3. Assessing the impact of long-term miscarriage on psychological experience

    Time frame: Modification in the Perinatal Grief Scale score at 6 and 12 months post-miscarriage linked to the introduction of simulated announcement training

  4. Fertility assessment at 6 and 12 months

    Time frame: Time to decision to have a new pregnancy and increase in clinical pregnancy rates, progressive pregnancy rates > 14 weeks' amenorrhea at 6 and 12 months

  5. Comparing the difference of " Impact of event scale-revised" score in patients depending on whether they are cared for by an intern whose most recent training in prognosis was less than or more than 6 months ago

    Time frame: 18 months

  6. Comparing the difference of " Impact of event scale-revised" score in patients depending on whether they were cared for by an intern who had received a single training course less than 6 months old, or by an intern who had received two training courses

    Time frame: 18 months

07

Study locations

28 sites
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2024 (actual). Primary completion is estimated for Jun 2027, 31 months after the start.

Of 43 non-industry interventional studies with no phase under Abortion, Spontaneous, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 40. This study's planned 31 months is above that.

Counting every sponsor, half of 45 studies reached it within 27 months; a quarter within 12 and three quarters within 40.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 9, 2024
First posted
Oct 18, 2024
StartActual
Nov 11, 2024
Primary completionEst.
Jun 11, 2027
CompletionEst.
Jun 11, 2027
Last update
Jun 25, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 25, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06647849
Collaborators
Direction Générale de l'Offre de Soins
Responsible party
Sponsor
First posted
Oct 18, 2024
Start date
Nov 11, 2024
Primary completion
Jun 11, 2027 (estimated)
Completion
Jun 11, 2027 (estimated)
Last update
Jun 25, 2026

Study contacts

Guillaume Legendre, MD, PhD
study director · University Hospital of Angers

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion